Angeline Tan

Angeline Tan has a comprehensive work history in the pharmaceutical industry. Angeline is currently serving as the Vice President of R&D QA at Nektar Therapeutics since September 2020. Prior to this, they worked at Pharmacyclics, an AbbVie Company, for six years as the Senior Director of Clinical Quality Assurance from May 2014 to August 2020. Angeline also has experience at Merck, where they held the position of Director of Clinical Quality Management from 2009 to May 2014 and Associate Director of Clinical Quality Assurance from 2002 to 2008. Angeline began their career at Eli Lilly in 1998, working in the MQA department until 2002.

Angeline Tan has a Bachelor of Science (BSc) degree in Pharmacy from the National University of Singapore. Angeline also holds a Master of Science (MSc) degree in Clinical Pharmacy from the Queen's University of Belfast. However, no specific start or end years are provided for either of their educational experiences.